Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders

被引:42
作者
Ringelstein, Marius [1 ,2 ]
Harmel, Jens [1 ]
Zimmermann, Hanna [3 ,4 ,5 ,6 ,7 ,8 ]
Brandt, Alexander U. [3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Paul, Friedemann [3 ,4 ,5 ,6 ,7 ,8 ]
Haarmann, Axel [10 ]
Buttmann, Mathias [10 ,11 ]
Huemmert, Martin W. [12 ]
Trebst, Corinna [13 ]
Schroeder, Christoph [14 ]
Ayzenberg, Ilya [14 ,15 ]
Kleiter, Ingo [14 ]
Hellwig, Kerstin [14 ]
Havla, Joachim [17 ]
Kuempfel, Tania [17 ]
Jarius, Sven [18 ]
Wildemann, Brigitte [18 ]
Rommer, Paulus [19 ]
Weber, Martin S. [20 ,21 ]
Pellkofer, Hannah [17 ,21 ]
Roepke, Luise [22 ]
Geis, Christian [22 ]
Retzlaff, Nele [23 ]
Zettl, Uwe [23 ]
Deppe, Michael [24 ]
Klotz, Luisa [16 ,24 ]
Young, Kim [25 ,26 ]
Stellmann, Jan-Patrick [25 ,26 ]
Kaste, Matthias [27 ]
Kermer, Pawel [21 ,27 ]
Marouf, Wael [28 ]
Lauda, Florian [29 ]
Tumani, Hayrettin [29 ]
Graf, Jonas [1 ]
Klistorner, Alexander [30 ]
Hartung, Hans-Peter [1 ]
Aktas, Orhan [1 ]
Albrecht, Philipp [1 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Fac Med, Dept Neurol, Dusseldorf, Germany
[2] Heinrich Heine Univ Dusseldorf, LVR Klinikum, Ctr Neurol & Neuropsychiat, Dept Neurol, Dusseldorf, Germany
[3] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany
[4] Charite Univ Med Berlin, Expt & Clin Res Ctr, Berlin, Germany
[5] Free Univ Berlin, Berlin, Germany
[6] Humboldt Univ, Berlin, Germany
[7] Berlin Inst Hlth, Berlin, Germany
[8] Max Delbruck Ctr Mol Med, Berlin, Germany
[9] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA
[10] Univ Wurzburg, Dept Neurol, Wurzburg, Germany
[11] Caritas Hosp, Dept Neurol, Bad Mergentheim, Germany
[12] Hannover Med Sch, Clin Neuroimmunol & Neurochem, Hannover, Germany
[13] Hannover Med Sch, Dept Neurol, Hannover, Germany
[14] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany
[15] Sechenov First Moscow State Med Univ, Dept Neurol, Moscow, Russia
[16] Marianne Strauss Klin, Behandlungszentrum Kempfenhausen Multiple Skleros, Berg, Germany
[17] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Clin Neuroimmunol, Munich, Germany
[18] Heidelberg Univ, Dept Neurol, Mol Neuroimmunol Grp, Heidelberg, Germany
[19] Med Univ Vienna, Dept Neurol, Vienna, Austria
[20] Univ Med Ctr Gottingen, Inst Neuropathol, Gottingen, Germany
[21] Univ Med Ctr Gottingen, Dept Neurol, Gottingen, Germany
[22] Jena Univ Hosp, Dept Neurol, Jena, Germany
[23] Univ Rostock, Dept Neurol, Neuroimmunol Sect, Rostock, Germany
[24] Univ Munster, Dept Neurol, Munster, Germany
[25] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany
[26] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & MS, Hamburg, Germany
[27] Nordwest Hosp Sanderhusch, Dept Neurol, Sande, Germany
[28] Helios Hanseklinikum Stralsund, Dept Neurol, Stralsund, Germany
[29] Univ Ulm, Dept Neurol, Ulm, Germany
[30] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia
关键词
NEUROMYELITIS-OPTICA; MULTIPLE-SCLEROSIS; CLINICAL-FEATURES; FELLOW EYES; FOLLOW-UP; PATHOLOGY; VISION;
D O I
10.1212/WNL.0000000000008684
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To investigate if patients with neuromyelitis optica spectrum disorder (NMOSD) develop subclinical visual pathway impairment independent of acute attacks. Methods A total of 548 longitudinally assessed full-field visual evoked potentials (VEP) of 167 patients with NMOSD from 16 centers were retrospectively evaluated for changes of P100 latencies and P100-N140 amplitudes. Rates of change in latencies (RCL) and amplitudes (RCA) over time were analyzed for each individual eye using linear regression and compared using generalized estimating equation models. Results The rates of change in the absence of optic neuritis (ON) for minimal VEP intervals of >= 3 months between baseline and last follow-up were +1.951 ms/y (n = 101 eyes; SD = 6.274; p = 0.012) for the P100 latencies and -2.149 mu V/y (n = 64 eyes; SD = 5.013; p = 0.005) for the P100-N140 amplitudes. For minimal VEP intervals of >= 12 months, the RCL was +1.768 ms/y (n = 59 eyes; SD = 4.558; p = 0.024) and the RCA was -0.527 mu V/y (n = 44 eyes; SD = 2.123; p = 0.111). The history of a previous ON >6 months before baseline VEP had no influence on RCL and RCA. ONs during the observational period led to mean RCL and RCA of +11.689 ms/y (n = 16 eyes; SD = 17.593; p = 0.003) and -1.238 mu V/y (n = 11 eyes; SD = 3.708; p = 0.308), respectively. Conclusion This first longitudinal VEP study of patients with NMOSD provides evidence of progressive VEP latency delay occurring independently of acute ON. Prospective longitudinal studies are needed to corroborate these findings and help to interpret the clinical relevance.
引用
收藏
页码:E407 / E418
页数:12
相关论文
共 36 条
  • [11] Neuromyelitis optica: clinical features, immunopathogenesis and treatment
    Jarius, S.
    Wildemann, B.
    Paul, F.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 176 (02) : 149 - 164
  • [12] Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
    Jarius, Sven
    Ruprecht, Klemens
    Wildemann, Brigitte
    Kuempfel, Tania
    Ringelstein, Marius
    Geis, Christian
    Kleiter, Ingo
    Kleinschnitz, Christoph
    Berthele, Achim
    Brettschneider, Johannes
    Hellwig, Kerstin
    Hemmer, Bernhard
    Linker, Ralf A.
    Lauda, Florian
    Mayer, Christoph A.
    Tumani, Hayrettin
    Melms, Arthur
    Trebst, Corinna
    Stangel, Martin
    Marziniak, Martin
    Hoffmann, Frank
    Schippling, Sven
    Faiss, Juergen H.
    Neuhaus, Oliver
    Ettrich, Barbara
    Zentner, Christian
    Guthke, Kersten
    Hofstadt-van Oy, Ulrich
    Reuss, Reinhard
    Pellkofer, Hannah
    Ziemann, Ulf
    Kern, Peter
    Wandinger, Klaus P.
    Bergh, Florian Then
    Boettcher, Tobias
    Langel, Stefan
    Liebetrau, Martin
    Rommer, Paulus S.
    Niehaus, Sabine
    Muench, Christoph
    Winkelmann, Alexander
    Zettl U, Uwe K.
    Metz, Imke
    Veauthier, Christian
    Sieb, Joern P.
    Wilke, Christian
    Hartung, Hans P.
    Aktas, Orhan
    Paul, Friedemann
    [J]. JOURNAL OF NEUROINFLAMMATION, 2012, 9
  • [13] Normal-appearing white matter demyelination in neuromyelitis optica spectrum disorder
    Jeong, I. H.
    Choi, J. Y.
    Kim, S. -H.
    Hyun, J. -W.
    Joung, A.
    Lee, J.
    Kim, H. J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 (04) : 652 - 658
  • [14] Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder
    Jeong, In Hye
    Kim, Ho Jin
    Kim, Nam-Hee
    Jeong, Kyoung Sook
    Park, Choul Yong
    [J]. JOURNAL OF NEUROLOGY, 2016, 263 (07) : 1343 - 1348
  • [15] Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
    Kleiter, Ingo
    Gahlen, Anna
    Borisow, Nadja
    Fischer, Katrin
    Wernecke, Klaus-Dieter
    Wegner, Brigitte
    Hellwig, Kerstin
    Pache, Florence
    Ruprecht, Klemens
    Havla, Joachim
    Krumbholz, Markus
    Kuempfel, Tania
    Aktas, Orhan
    Hartung, Hans-Peter
    Ringelstein, Marius
    Geis, Christian
    Kleinschnitz, Christoph
    Berthele, Achim
    Hemmer, Bernhard
    Angstwurm, Klemens
    Stellmann, Jan-Patrick
    Schuster, Simon
    Stangel, Martin
    Lauda, Florian
    Tumani, Hayrettin
    Mayer, Christoph
    Zeltner, Lena
    Ziemann, Ulf
    Linker, Ralf
    Schwab, Matthias
    Marziniak, Martin
    Bergh, Florian Then
    Hofstadt-van Oy, Ulrich
    Neuhaus, Oliver
    Winkelmann, Alexander
    Marouf, Wael
    Faiss, Juergen
    Wildemann, Brigitte
    Paul, Friedemann
    Jarius, Sven
    Trebst, Corinna
    [J]. ANNALS OF NEUROLOGY, 2016, 79 (02) : 206 - 216
  • [16] Longitudinal Study of Retinal Nerve Fiber Layer Thickness and Macular Volume in Patients With Neuromyelitis Optica Spectrum Disorder
    Manogaran, Praveena
    Traboulsee, Anthony L.
    Lange, Alex P.
    [J]. JOURNAL OF NEURO-OPHTHALMOLOGY, 2016, 36 (04) : 363 - 368
  • [17] Aquaporin 4 Expression and Tissue Susceptibility to Neuromyelitis Optica
    Matiello, Marcelo
    Schaefer-Klein, Janet
    Sun, David
    Weinshenker, Brian G.
    [J]. JAMA NEUROLOGY, 2013, 70 (09) : 1118 - 1125
  • [18] Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica
    Neto, Silvio P.
    Alvarenga, Regina M. P.
    Vasconcelos, Claudia C. F.
    Alvarenga, Marina P.
    Pinto, Luiz C.
    Pinto, Vera L. R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (02) : 173 - 178
  • [19] Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency
    Niklas, A.
    Sebraoui, H.
    Hess, E.
    Wagner, A.
    Bergh, F. Then
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (01) : 68 - 74
  • [20] ISCEV standard for clinical visual evoked potentials: (2016 update)
    Odom, J. Vernon
    Bach, Michael
    Brigell, Mitchell
    Holder, Graham E.
    McCulloch, Daphne L.
    Mizota, Atsushi
    Tormene, Alma Patrizia
    [J]. DOCUMENTA OPHTHALMOLOGICA, 2016, 133 (01) : 1 - 9